Video: FDA's TAVI panel in review with Dr. Michael Gibson

Justine Varieur Cadet | August 01, 2011 | Cardiovascular Business | Interventional Cardiology

Video: Justine Cadet speaks with C. Michael Gibson, MD
Interventional Cardiologist
Beth Israel Deaconess Medical Center
Boston, Mass.

BOSTON--Justine Cadet from Cardiovascular Business sat down with C. Michael Gibson, MD, interventional cardiologist at the Beth Israel Deaconess Medical Center in Boston, to discuss the FDA’s Circulatory System Devices Panel, which convened July 20 in Bethesda, Md., and recommended approval of the Sapien transcatheter heart valve (Edwards Lifesciences), based on the results of the Cohort B of the PARTNER trial.

The discussion traversed such topics as the changes to the requested indication, the safety considerations, the final vote and the post-approval studies.

Justine Varieur Cadet

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business

Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Related Content

Around the web